ruscogenin has been researched along with 1-2-dipalmitoylphosphatidylglycerol* in 1 studies
1 other study(ies) available for ruscogenin and 1-2-dipalmitoylphosphatidylglycerol
Article | Year |
---|---|
Ruscogenin interacts with DPPC and DPPG model membranes and increases the membrane fluidity: FTIR and DSC studies.
Ruscogenin, a kind of steroid saponin, has been shown to have significant anti-oxidant, anti-inflammatory, and anti-thrombotic characteristics. Furthermore, it has the potential to be employed as a medicinal medication to treat a variety of acute and chronic disorders. The interaction of a drug molecule with cell membranes can help to elucidate its system-wide protective and therapeutic effects, and it's also important for its pharmacological activity. The molecular mechanism by which ruscogenin affects membrane architecture is still a mystery. Ruscogenin's interaction with zwitterionic dipalmitoyl phosphatidylcholine (DPPC) and anionic dipalmitoyl phosphatidylglycerol (DPPG) multilamellar vesicles (MLVs) was studied utilizing two non-invasive approaches, including: Fourier Transform Infrared (FTIR) spectroscopy and Differential Scanning Calorimetry. Ruscogenin caused considerable alterations in the phase transition profile, order, dynamics and hydration state of head groups and glycerol backbone of DPPC and DPPG MLVs at all concentrations. The DSC results indicated that the presence of ruscogenin decreased the main phase transition temperature (T Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Fourier Analysis; Lipid Bilayers; Membrane Fluidity; Phosphatidylglycerols; Spectroscopy, Fourier Transform Infrared | 2023 |